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Abstract 20 
 21 
Tailed dsDNA bacteriophages frequently harbour structural proteins displaying 22 
peptidoglycan hydrolytic activities. The tape measure protein from Staphylococcus 23 
aureus bacteriophage vB_SauS-phiIPLA35 has a lysozyme-like and a peptidase_M23 24 
domain. This report shows that the lysozyme-like domain (TG1) has muramidase 25 
activity and exhibits in vitro lytic activity against live S. aureus cells, an activity that 26 
could eventually find use in the treatment of infections. 27 
28 
 3
The peptidoglycan layer is a barrier that bacteriophages must overcome to infect 29 
its bacterial host. In this regard, virions are provided with structural proteins containing 30 
catalytic domains that play roles in attachment to host cells through sugar binding or 31 
degradation of the polysaccharides on the cell surface (6). Murein hydrolases appear to 32 
be widespread in virions of bacteriophages infecting Gram-positive and Gram-negative 33 
bacteria, where the enzyme is either part of a large protein or found associated with 34 
other structural components of the virion (10). These peptidoglycan hydrolases have 35 
been related to modification in the peptidoglycan structure necessary for phage 36 
infection. Sequence analysis revealed that peptidoglycan degrading domains are 37 
frequently located in Tape Measure Proteins (TMPs) (6), although in most of the cases 38 
its activity has not been analysed. The TMPs of several mycobacteriophages contain 39 
domains that mediate peptidoglycan degradation and play an essential role when these 40 
phages infect stationary phase cells (12). In a similar way, phage T5 straight tail fiber is 41 
a multifunctional protein not only acting as a tape measure protein but carries also 42 
fusogenic and muralytic activities (3). In other phages, virion-associated proteins with 43 
peptidoglycan hydrolytic activity might play a similar role in the phage infection 44 
process. Thus, the bacteriophage T7 gp16 with transglycosylase activity is not essential 45 
for phage growth, but was shown to be beneficial during infection of E. coli cells grown 46 
to high cell density or low temperatures, where the murein is more highly cross-linked 47 
(9). Furthermore, the amino-terminal end of the bacteriophage PRD1 structural protein 48 
P7 carries a conserved transglycosylase domain, which is located at the particle vertices 49 
and is involved in the early steps of the PRD1 life cycle (16). Additionally, the tail 50 
baseplate of bacteriophage T4 contains an essential protein, gp5, which possesses 51 
lysozyme activity and functions to locally dissolve the periplasmic cell wall (1).  52 
 4
S. aureus bacteriophage vB_SauS-phiIPLA35 (in short, phiIPLA35) is a member 53 
of the Siphoviridae family, previously isolated from dairy samples (7). The complete 54 
genome sequence was determined (GenBank EU861005) and zymogram analysis of 55 
virions revealed the presence of a phiIPLA35 virion-associated muralytic enzyme (8). In 56 
this study, a muramidase domain has been described as part of the TMP, a structural 57 
component of phage phiIPLA35. The lytic activity of this protein against S. aureus cells 58 
has been determined and its cleavage sites in the peptidoglycan identified. 59 
 The tape measure protein (TMP) of phage phiIPLA35 has two putative 60 
catalytic domains. Computer-based similarity searches using BLASTp revealed that 61 
protein TMP (gp50, 2066 aa, YP_002332413.1), showed 98-99% similarity with TMPs 62 
from the staphylococcal phages 42E, phi47, phi12, phiSLT, tp310-2, and phi3A. 63 
Conserved-domain analyses of TMP using InterProScan identified a structural 64 
conserved domain, tape_meas_TP901 (from aa 323-666), related with the tail length in 65 
TP901-like phages (11). In addition, two typical catalytic domains were observed: a 66 
peptidase_M23 domain (from aa 1706-1796) and a lysozyme-like domain (from aa 67 
1829-1920). Members of peptidase family M23 are zinc metallopeptidases with Gly-68 
Gly endopeptidase activity and many of them such as lysostaphin have specific 69 
hydrolytic activity on peptidoglycan (17). Lysozyme activities catalyze the cleavage of 70 
the beta-1,4-glycosidic bond between N-acetylmuramic acid (MurNAc) and N-acetyl-71 
D-glucosamine (GlcNAc). Lysozyme catalytic domains are often found in cell wall 72 
hydrolases from S. aureus phages (14). However, only phages 42E, phi47, phi12, 73 
phiSLT, tp310-2, and phi3A revealed a TMP with a lysozyme-like domain homolog to 74 
phiIPLA35 TMP.  75 
The lysozyme-like domain (TG1) of TMP has peptidoglycan muramidase 76 
activity. To confirm the predicted peptidoglycan hydrolytic activity of TG1, a truncated 77 
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protein (from aa 1829 to 2066) containing the lysozyme-like domain was cloned and 78 
overexpressed. phiIPLA35 tg1 fragment (717 bp) was codon-optimized based on the E. 79 
coli codon usage and commercially synthesized (Biomedal, Sevilla, Spain). Then tg1-80 
opt was subcloned between the NdeI and XhoI sites in the multi cloning site of the 81 
inducible expression vector pET21a (EMD Biosciences, San Diego, CA), which 82 
introduces a C-terminal 6xHis-tag. E. coli BL21(DE3)/pLysS was used in protein 83 
expression assays (19). Purification of TG1 (30.1 kDa) was performed by Ni-NTA 84 
chromatography (15). Peptidoglycan cleavage site determination was carried out by 85 
reverse-phase HPLC and Mass Spectrometry (MS) (2). 2 mg of S. aureus SA113 86 
peptidoglycan was isolated by CeCoLabs UG, Tübingen, incubated overnight with 27 87 
μg of TG1 in a final volume of 250 μl at 37ºC with shaking in MES-NaOH 50 mM, pH 88 
5, buffer. Samples were boiled 3 min to stop the reaction, centrifuged at 14,000 × g for 89 
5 min and the soluble fraction was separated by reverse-phase HPLC using a Nucleosil 90 
100 column (C18; 125 × 4.6 mm; 5 µm; Maisch GmbH, Ammerbuch, Germany) and a 91 
water/0.1% TFA: 80% acetonitrile/0.1% TFA gradient for 150 min at flow rate of 0.5 92 
ml/min. The molecular masses of the muropeptides were determined by LC-MS. The 93 
primary product of TG1 digestion was the disaccharide pentapeptide GlcNAc-(β1–4)-94 
MurNAc-(L-Ala-D-iGln-L-Lys-(Gly)-D-Ala-COOH) (Mr 951.7) which in MS yields a 95 
peak with m/z 952.6 (protonated) and m/z 950.5 (unprotonated) (Fig. 1). This main 96 
digestion product is also obtained with the mutanolysin digestion of the same 97 
peptidoglycan (data not shown). Therefore, TG1 is most likely a muramidase that can 98 
digest MurNAc-GlcNAc linkages.  99 
There are no previous reports about the involvement of virion-associated 100 
peptidoglycan hydrolases in S. aureus phage infection. However, the presence in phages 101 
phiIPLA88 and phiMR11 of proteins with muralytic activities might indicate its 102 
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involvement in local cell-wall degradation, allowing the subsequent introduction of 103 
DNA into the host cytoplasm (13, 14). In phiIPLA35, the presence of an active 104 
muramidase domain in the TMP could also indicate its contribution in the infection 105 
process, taking into account that no other virion-associated proteins with peptidoglycan 106 
hydrolase activity were identified in this phage (8).  107 
The TG1 domain displays lytic activity against S. aureus cells. The 108 
peptidoglycan hydrolytic ability of TG1 was assayed by zymogram analysis using 10 ml 109 
15% (w/v) SDS-PAGE with or without S. aureus Sa9 cells from a 300 ml culture 110 
(A600nm 0.5) embedded in the gel . A clear band consistent with the predicted molecular 111 
mass (30.1 kDa) was observed after analysis of 5 μg of TG1 protein in the SDS-PAGE 112 
containing the staphylococcal cells. This clear band was the result of the lysis of the S. 113 
aureus cells embedded in the gel (Figure 2A, zymogram). Moreover, in order to assess 114 
the lytic activity of TG1 against live S. aureus Sa9 cells, turbidity reduction assays were 115 
performed with S. aureus cells grown to logarithmic phase (OD600nm = 0.4–0.6), 116 
harvested and resuspended in buffer A (MES-NaOH 50 mM, pH 5) to OD600 1.0. As 117 
shown in Figure 2B, a 32.7% decrease in OD600nm was obtained after 120 min of 118 
incubation at 37ºC with 5 µM of TG1 (specific activity 0.00138 expressed as ΔOD600nm 119 
min-1μM-1), which indicated the lytic ability of the TG1 protein. This result was 120 
confirmed by a cell viability assay using exponentially growing cells which were 121 
recovered by centrifugation, washed and resuspended in buffer A to OD600 0.1. Then, 5 122 
µM TG1 was mixed with S. aureus Sa9 live cells to a final concentration of 4 × 106 123 
CFU/ml and incubated for 30 min, 1, 2 and 3 h at 37 ºC. Staphylococcal viable counts 124 
were reduced by 75.5%, 77.5%, 98% and 99.7%, respectively, compared with the 125 
untreated control cultures (Figure 2C). These results support the functionality of the 126 
putative lysozyme-like domain found by the bioinformatic analysis. Nevertheless, their 127 
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activity seems to be somewhat weaker than that shown by other staphylococcal virion-128 
associated peptidoglycan hydrolases such phiIPLA88 HydH5 (14) and phiMR11 gp61 129 
(13). This lower specific activity (about 23-fold lower compared to HydH5) could be 130 
due to the presence of only one catalytic domain, the lysozyme-like domain, while 131 
HydH5 showed two active catalytic domains (14). Nevertheless, the peptidoglycan 132 
hydrolytic activity of TMP as part of phiIPLA35 virions could also be enhanced by the 133 
peptidase_M23 domain. Therefore, although TG1 lytic activity was moderate against 134 
staphylococci, further investigation is worthwhile. We previously reported that the 135 
fusion of a staphylococcal SH3b cell wall-binding domain to the HydH5 CHAP domain 136 
resulted in a 4.8-fold increase of its lytic activity (15). Furthermore, it is plausible to 137 
swap different catalytic domains by protein engineering generating proteins with 138 
improved lytic activity (4, 15). In this context, the search of catalytic domains with new 139 
biochemical properties is justified. Moreover, with the increasing prevalence of 140 
antibiotic-resistant pathogens, the possibility of using phage lytic proteins as novel 141 
therapeutic antibacterial agents has a renewed interest. This is not only supported by its 142 
ability to kill bacteria but also by the low probability of resistance development. In fact, 143 
some phage endolysins have already been successfully assayed in preclinical trials 144 
involving animal models of human diseases (5). Additionally, chimeric lysins consisting 145 
of an endopeptidase domain of the streptococcal phage lysin λSA2 and SH3b cell 146 
binding domains from the staphylococcal phage lysin LysK and lysostaphin showed 147 
antimicrobial activity against S. aureus-induced mastitis in mouse models (18). 148 
In conclusion, the identification of a muramidase activity associated to the phage 149 
phiIPLA35 tape measure protein showing lytic capabilities against live S. aureus cells is 150 
reported. This novel peptidoglycan lytic domain may be of help for designing potent 151 
antimicrobials against this pathogen. 152 
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Figures 239 
 240 
Figure 1. MS analysis of the overnight digestion of 2 mg of S. aureus SA113 241 
peptidoglycan with 27 μg of TG1 in MES-NaOH 50 mM, pH 5 buffer. The primary 242 
product of the digestion was the disaccharide pentapeptide GlcNAc-(β1–4)-MurNAc-243 
(L-Ala-D-iGln-L-Lys-(Gly)-D-Ala-COOH) (Mr 951.7)  244 
 245 
Figure 2. Lytic activity of TG1 protein against S. aureus. A) 5 µg of nickel affinity 246 
purified TG1 (30.1 kDa) were resolved on a 15% SDS-PAGE in the absence (SDS-247 
PAGE, lane 1) or in the presence (zymogram, lane 2) of S. aureus Sa9 cells. Gels were 248 
either stained with Coomassie.blue (SDS-PAGE) or incubated in water for 1 h at room 249 
temperature (zymogram). Lane M: Standard molecular mass marker in kDa (Prestained 250 
SDS-PAGE Standards, broad range, BioRad Laboratories). B) Representative turbidity 251 
reduction assay performed by challenging S. aureus Sa9 cells to 5 µM of TG1 for 120 252 
min at 37 ºC. Light grey line indicates the untreated cultures (S. aureus Sa9 cells + 253 
MES-NaOH 50 mM, pH 5); dark grey line indicates treated cultures (S. aureus Sa9 cells 254 
+ 5 µM of TG1). C) Viability test performed by challenging S. aureus Sa9 cells to 5 µM 255 
of TG1 for 30 min, 1, 2 and 3 h at 37 ºC (light grey bars). Dark grey bars indicate 256 
untreated cultures (S. aureus Sa9 + MES-NaOH 50 mM, pH 5). Error bars are the 257 
means ± standard deviations of two independent assays. 258 
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